NASD · Healthcare · Medical Devices · USA
Orthofix Medical Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
Orthofix Medical is a global medical technology company that manufactures devices and therapies for treating spinal diseases, bone healing, and limb reconstruction conditions. Operating through Global Spine and Global Limb Reconstruction segments, the company offers implantable systems, regenerative solutions, navigation technology, and bone graft products. Its offerings are distributed worldwide to hospitals, surgical centers, and healthcare providers.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Orthofix Medical Inc stock.
Undervalued: intrinsic value $42.33 per share, market price $9.07, margin of safety 78.6% (as of 2026-10-30).
A 2.2x revenue multiple, discounted for its losses, values the shares at $42.33; the price of $9.07 is 79% below that value.
Leak Score: 48/100 on 8 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
OFIX is undervalued (as of the 2026-10-30 close). A 2.2x revenue multiple, discounted for its losses, values the shares at $42.33; the price of $9.07 is 79% below that value.
$42.33 per share (as of the 2026-10-30 close), against a market price of $9.07. That is a margin of safety of 78.6%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
48 out of 100, which we rate "On Watch", on 8 of 12 value investing signals.